Get the Weekly Intelligence Brief — top committee picks every Sunday.
CNC · NYSE · STOCK

Centene (CNC) Stock Analysis

Healthcare Updated October 10, 2026
$65.37
52W $31.63 – $69.63
65/100
$32.29B
-6.3
1.13
AI Committee Verdict
Buy
65/100
Conviction: High · 83% agreement · 6 analysts
+0.7%
-2.9%
0.26:1
High
⚠
Buy rating, but near-term risk/reward is unfavorable
The long-term recommendation is based on the composite investment score. The near-term risk/reward is based on nearby support and resistance levels. These can differ when a strong company trades close to resistance with support further below.

Is CNC Bullish or Bearish?

Bullish. Innellis AI committee rates Centene Corporation (CNC) Buy with a composite score of 65/100 , based on 6 analysts with 83% agreement. Last updated October 10, 2026.

What Would Change This View

Upgrade to Strong Buy
Requires a committee score of 75.0 — +10.29 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Watch
Requires the score to fall below 55.0 — -9.71 from today. The band boundary is 60.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.60 across 26 articles, 14d). Portfolio Manager remains cautious — sector concentration is already high (hhi 2796.97). This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • Price-to-book of 1.0x is a discount to asset value — Value
  • 4 consecutive earnings beats -- consistent execution — Growth
  • MACD histogram positive -- bullish momentum — Technical
  • Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
  • News sentiment is positive (+0.60 across 26 articles, 14d) — News
Bear Case
  • ROE of only -24.0% -- cheap may mean cheap for a reason — Value
  • Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of October 10, 2026
Overall Committee Score
65/100
Agreement
83%
Analysts
6
Conviction
High
Sector Rank
Top 5%
of 192 Healthcare peers
Value Analyst neutral
55 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
+ Price-to-book of 1.0x is a discount to asset value
− ROE of only -24.0% -- cheap may mean cheap for a reason
Growth Analyst bullish
60 / 100 · High confidence
Strong, accelerating growth with consistent execution
+ 4 consecutive earnings beats -- consistent execution
− Growth rate is decelerating quarter over quarter -- the trend line matters more than the level
Technical Analyst bullish
61 / 100 · High confidence
Price action is constructive -- trend and momentum agree
+ MACD histogram positive -- bullish momentum
Risk Analyst bullish
70 / 100 · Low confidence
Risk profile is manageable -- leverage, volatility, and event exposure all look contained
Macro Analyst bullish
65 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst bullish
77 / 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.60 across 26 articles, 14d)
Portfolio Manager bearish
30 / 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 64.7 to 64.7.

Comparing 2026-10-09 to 2026-10-10 (1 day apart).

Technical Analysis

RSI (14)
62.5
Neutral
MACD Histogram
0.299
Bullish Momentum
Trend Direction
Sideways
Weekly: Sideways
Market Structure
Hh Hl
Support
$63.49
Resistance
$65.86
Bollinger %B
0.63
Inside Bands
Price vs Moving Averages
EMA 9
$64.14 Above
EMA 21
$64.16 Above
EMA 50
$64.20 Above
EMA 200
$56.55 Above

Fundamental Analysis

Valuation
100
Growth
75
Profitability
0
Financial Health
59
Cash Flow
70
Valuation
P/E Ratio -6.3×
P/B Ratio 1.43×
PEG Ratio 0.02
Dividend Yield 0.00%
52W High $69.63
52W Low $31.63
Quality & Growth
ROE -3344.4%
ROA -859.2%
Gross Margin 1612.5%
Operating Margin -281.8%
Revenue Growth YoY —
Debt / Equity 0.71
AI Fundamental Assessment
P/E ratio of -6.3 (inexpensive relative to a 15-40x range); Price-to-book of 1.4x; PEG ratio of 0.0 (under 1.0 suggests growth is undervalued relative to price); Return on equity of -33.4%; Return on assets of -8.6%; Net margin of -2.6%; Gross margin of 16.1%; Current ratio of 1.15 (tight short-term liquidity); Debt-to-equity of 0.71; Free cash flow per share is positive (18.16); Most recent quarter beat estimates by 129.0%; 4 consecutive earnings beats; EPS growth decelerating (+383.2% -> -25.5% QoQ); Average YoY EPS growth of 1668.8%; Analyst estimates rising over recent quarters
Get the Full CNC Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime